Tolperisone
Tolperisone is a centrally acting muscle relaxant used in the treatment of increased muscle tone and muscle spasms. It is commonly prescribed for conditions such as spasticity and muscle spasms associated with neurological disorders. Tolperisone is known for its ability to relieve muscle stiffness without causing sedation, which is a common side effect of many other muscle relaxants.
Pharmacology[edit]
Tolperisone acts primarily on the central nervous system. It is believed to work by blocking voltage-gated sodium and calcium channels, which reduces the excitability of motor neurons. This action helps in decreasing muscle tone and alleviating muscle spasms. Unlike other muscle relaxants, tolperisone does not have significant sedative effects, making it a preferred choice for patients who need to maintain alertness.
Uses[edit]
Tolperisone is used in the management of:
- Spasticity due to neurological disorders such as multiple sclerosis and cerebral palsy.
- Muscle spasms associated with musculoskeletal disorders.
- Postoperative muscle spasms.
Side Effects[edit]
Common side effects of tolperisone include:
Serious side effects are rare but may include allergic reactions such as rash, itching, and swelling.
Dosage[edit]
Tolperisone is typically administered orally in tablet form. The dosage varies depending on the condition being treated and the patient's response to the medication. It is important to follow the prescribing physician's instructions regarding dosage and duration of treatment.
Mechanism of Action[edit]
Tolperisone's mechanism of action involves the inhibition of voltage-gated sodium and calcium channels in the central nervous system. This inhibition reduces the release of neurotransmitters that are responsible for muscle contraction, thereby decreasing muscle tone and spasms.
History[edit]
Tolperisone was first introduced in the 1960s and has been used extensively in Europe and Asia for the treatment of muscle spasticity. It is not widely available in the United States but remains a popular choice in countries where it is approved for use.
